Cogent Biosciences Inc (COGT) — Capital Reinvestment Ratio
Latest as of December 2015:
0.11x
Cogent Biosciences Inc (COGT) has a Capital Reinvestment Ratio of 0.11x as of December 2015, meaning it reinvests 0% of its operating cash flow ($17.72 Million) in capital expenditures ($1.99 Million). See free cash flow generation of Cogent Biosciences Inc to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.11x
Capex / Operating Cash Flow
Operating Cash Flow
$17.72 Million
USD
Capital Expenditures
$1.99 Million
USD
Data as of
Dec 2015
Most recent filing
Cogent Biosciences Inc Capital Reinvestment Ratio (2015–2015)
This chart tracks Cogent Biosciences Inc's Capital Reinvestment Ratio across 1 annual periods.
Annual Capital Reinvestment Ratio for Cogent Biosciences Inc (2015–2015)
Year-by-year Capital Reinvestment Ratio for Cogent Biosciences Inc from 2015 to 2015. For live market cap and broader valuation context, see COGT market cap overview.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2015 | 0.11x | $17.72 Million | $1.99 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow